Other collaborating nodes
The MRC and EPSRC support six Molecular Pathology nodes across the UK, bringing researchers, clinicians and industry together to develop molecular diagnostic tools, to enable stratification across a range of diseases.
University of Glasgow
The Glasgow Molecular Pathology (GMP) Node will integrate pathology, genomics and informatics. It will be located at the Queen Elizabeth University Hospital campus where the University of Glasgow has already established a world-leading reputation in precision medicine, including the £20 million Stratified Medicine Scotland Innovation Centre, £32 million Imaging Centre of Excellence, and £30 million Queen Elizabeth Teaching and Learning Centre including incubators for industry.
University of Leicester
The air we breathe out contains a cocktail of volatile organic compounds that give a snapshot of the biological processes taking place in the lung and beyond. The East Midlands Breathomics Pathology Node (EMBER) will help develop breath analysis tests that use the same technology as that used to detect explosives in war zones. It’s hoped these could give an instant diagnosis and help doctors pick the best treatments for a range of conditions, including cancers, respiratory infections and diseases such as asthma and chronic obstructive pulmonary disease.
University of Manchester
Developing biomarker based molecular pathology tests will be a major focus of the Manchester Molecular Pathology Innovation Centre (MMPathIC) with the initial work aimed at creating tests to diagnose, pick the right treatment and asses the response to treatment for a range of inflammatory conditions including rheumatoid arthritis, lupus and psoriasis.
The Newcastle Proximity Laboratory will focus on developing new lab tests for rare and chronic diseases and will also be involved in training the next generation of molecular pathologists who will be vital in the delivery of precision medicine
University of Nottingham
Nottingham Molecular Pathology Node (NMPN) for Integrated Multi-platform Biomarker Research and Knowledge Transfer will bring together informatics, computational modelling and molecular pathology to find new biomarkers for a range of diseases – particularly those affecting the digestive and respiratory systems and the liver. These new markers will help doctors pick the best treatments for their patients.